Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with 177 lu-dotatate in the phase III netter-1 trial

on behalf of the NETTER-1 Study Group

Research output: Contribution to journalArticlepeer-review

82 Scopus citations

Fingerprint Dive into the research topics of 'Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with <sup>177</sup> lu-dotatate in the phase III netter-1 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences